Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1430073

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1430073

MEA Hydrocephalus Market - Industry Trends and Forecast to 2034

PUBLISHED:
PAGES: 152 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

The Middle East and Africa hydrocephalus market is expected to reach USD 73,700.58 thousand by 2031 from USD 53,050.71 thousand in 2023, growing with a CAGR of 4.4% in the forecast period of 2024 to 2031.

Market Segmentation

Middle East and Africa Hydrocephalus Market, By Type (Congenital Hydrocephalus, Acquired Hydrocephalus, Normal-Pressure Hydrocephalus, and Ex-Vacuo Hydrocephalus), Diagnostic & Treatment (Diagnosis and Treatment), End Users (Hospitals, Clinics, Diagnostic Centers, and Academic Institutions and Research Organizations), Country (Saudi Arabia, South Africa, U.A.E., Israel, Egypt, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2031.

Overview of Middle East and Africa Hydrocephalus Market Dynamics

  • Driver
  • Increasing incidence of neurological conditions
  • Restraint
  • Poor reimbursement policies
  • Opportunity
  • Growing support by healthcare organizations and government bodies

Market Players

Some of the key market players operating in the Middle East and Africa hydrocephalus market are:

  • Aesculap, Inc. - a B. Braun company
  • Integra LifeSciences
  • G.SURGIWEAR LTD
  • MOLLER Medical GmbH
  • Anuncia Inc.
  • CHRISTOPH MIETHKE GMBH & CO. KG
  • KARL STORZ SE & Co. KG
  • Proteses, inc.
  • Medtronic
  • natus
  • Desu Medical
  • Bicakcilar
  • Spiegelberg GmbH & Co.KG
  • Sophysa
  • KANEKA MEDIX CORP

TABLE OF CONTENTS

1 INTRODUCTION 18

  • 1.1 OBJECTIVES OF THE STUDY 18
  • 1.2 MARKET DEFINITION 18
  • 1.3 OVERVIEW OF MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET 18
  • 1.4 LIMITATIONS 19
  • 1.5 MARKETS COVERED 19

2 MARKET SEGMENTATION 22

  • 2.1 MARKETS COVERED 22
  • 2.2 GEOGRAPHICAL SCOPE 23
  • 2.3 YEARS CONSIDERED FOR THE STUDY 24
  • 2.4 CURRENCY AND PRICING 24
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 25
  • 2.6 MULTIVARIATE MODELLING 28
  • 2.7 TYPE LIFELINE CURVE 28
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 29
  • 2.9 DBMR MARKET POSITION GRID 30
  • 2.10 VENDOR SHARE ANALYSIS 31
  • 2.11 SECONDARY SOURCES 32
  • 2.12 ASSUMPTIONS 32

3 EXECUTIVE SUMMARY 33

4 PREMIUM INSIGHTS 35

5 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET: REGULATIONS 36

  • 5.1 REGULATIONS IN U.S. 36
  • 5.2 REGULATIONS IN EUROPE 36
  • 5.3 REGULATIONS IN INDIA 36
  • 5.4 REGULATIONS IN JAPAN 37
  • 5.5 REGULATIONS IN BRAZIL 37

6 MARKET OVERVIEW 38

  • 6.1 DRIVERS 40
    • 6.1.1 INCREASING INCIDENCE OF NEUROLOGICAL CONDITIONS 40
    • 6.1.2 GROWING NUMBER OF NEW-BORNS AFFECTED BY HYDROCEPHALUS 40
    • 6.1.3 INCREASING ADAPTATION OF ADVANCED PROGRAMMABLE VALVES 41
    • 6.1.4 RISING AWARENESS ABOUT HYDROCEPHALUS 41

  • 6.2 RESTRAINTS 42
    • 6.2.1 POOR REIMBURSEMENT POLICIES 42
    • 6.2.2 DELETERIOUS COMPLICATIONS WITH HYDROCEPHALUS DEVICES 42
  • 6.3 OPPORTUNITIES 43
    • 6.3.1 GROWING SUPPORT BY HEALTHCARE ORGANIZATIONS AND GOVERNMENT BODIES 43
    • 6.3.2 GROWING HEALTHCARE EXPENDITURE 44
    • 6.3.3 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYERS 44
  • 6.4 CHALLENGES 45
    • 6.4.1 HIGH PRODUCT RECALL SCENARIO 45
    • 6.4.2 LACK OF ACCESSIBILITY OF HYDROCEPHALUS PRODUCTS 45

7 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET, BY TYPE 46

  • 7.1 OVERVIEW 47
  • 7.2 CONGENITAL HYDROCEPHALUS 50
  • 7.3 ACQUIRED HYDROCEPHALUS 50
  • 7.4 NORMAL-PRESSURE HYDROCEPHALUS 51
  • 7.5 EX-VACUO HYDROCEPHALUS 51

8 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT 52

  • 8.1 OVERVIEW 53
  • 8.2 DIAGNOSTICS 56
    • 8.2.1 MAGNETIC RESONANCE IMAGING (MRI) 56
    • 8.2.2 CT SCAN - HEAD 56
    • 8.2.3 HEAD ULTRASOUND 57
  • 8.3 TREATMENT 57
    • 8.3.1 SURGERY - SHUNT INSERTION, BY PRODUCT TYPE 58
      • 8.3.1.1 HYDROCEPHALUS VALVES 58
      • 8.3.1.2 HYDROCEPHALUS CATHETERS 58
        • 8.3.1.2.1 ADJUSTABLE PRESSURE VALVES 58
        • 8.3.1.2.2 FIX PRESSURE VALVES 59
    • 8.3.2 SURGERY - SHUNT INSERTION, BY AGE GROUP 59
      • 8.3.2.1 PEDIATRIC 59
      • 8.3.2.2 ADULT 59
    • 8.3.3 VENTRICULOSTOMY 59
    • 8.3.4 MEDICATION 59
    • 8.3.5 TREATMENT, BY AGE GROUP 60
    • 8.3.6 INFANTS 60
    • 8.3.7 CHILDREN 60
    • 8.3.8 ADULTS 60

9 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET, BY END USERS 61

  • 9.1 OVERVIEW 62
  • 9.2 HOSPITALS 65
  • 9.3 CLINICS 65
  • 9.4 DIAGNOSTIC CENTERS 66
  • 9.5 ACADEMIC INSTITUTIONS AND RESEARCH ORGANIZATIONS 66
    • 9.5.1 HOSPITALS 67
    • 9.5.2 AMBULATORY AND SURGICAL CENTERS 67
    • 9.5.3 HOSPITALS 67
    • 9.5.4 CLINICS 67
    • 9.5.5 DIAGNOSTIC CENTER 68
    • 9.5.6 SURGICAL CENTERS 68
    • 9.5.7 AMBULATORY SURGICAL CENTERS 68
    • 9.5.8 OTHERS 68

10 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET, BY REGION 69

  • 10.1 ASIA-PACIFIC 71
    • 10.1.1 JAPAN 76
    • 10.1.2 CHINA 80
    • 10.1.3 SOUTH KOREA 84
    • 10.1.4 INDIA 88
    • 10.1.5 AUSTRALIA 92
    • 10.1.6 SINGAPORE 96
    • 10.1.7 THAILAND 100
    • 10.1.8 MALAYSIA 104
    • 10.1.9 INDONESIA 108
    • 10.1.10 PHILIPPINES 112
    • 10.1.11 VIETNAM 116
    • 10.1.12 REST OF ASIA-PACIFIC 120

11 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET, COMPANY LANDSCAPE 121

  • 11.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA 121

12 SWOT ANALYSIS 122

13 COMPANY PROFILE 123

  • 13.1 MEDTRONIC 123
    • 13.1.1 COMPANY SNAPSHOT 123
    • 13.1.2 REVENUE ANALYSIS 123
    • 13.1.3 COMPANY SHARE ANALYSIS 124
    • 13.1.4 PRODUCT PORTFOLIO 124
    • 13.1.5 RECENT DEVELOPMENTS 124
  • 13.2 AESCULAP, INC. - A B. BRAUN COMPANY 125
    • 13.2.1 COMPANY SNAPSHOT 125
    • 13.2.2 COMPANY SHARE ANALYSIS 125
    • 13.2.3 PRODUCT PORTFOLIO 126
    • 13.2.4 RECENT DEVELOPMENT 126
  • 13.3 INTEGRA LIFESCIENCES 127
    • 13.3.1 COMPANY SNAPSHOT 127
    • 13.3.2 REVENUE ANALYSIS 127
    • 13.3.3 COMPANY SHARE ANALYSIS 128
    • 13.3.4 PRODUCT PORTFOLIO 128
    • 13.3.5 RECENT DEVELOPMENT 129
  • 13.4 SPIEGELBERG GMBH & CO. KG 130
    • 13.4.1 COMPANY SNAPSHOT 130
    • 13.4.2 COMPANY SHARE ANALYSIS 130
    • 13.4.3 PRODUCT PORTFOLIO 131
    • 13.4.4 RECENT DEVELOPMENT 131
  • 13.5 BICAKCILAR 132
    • 13.5.1 COMPANY SNAPSHOT 132
    • 13.5.2 COMPANY SHARE ANALYSIS 132
    • 13.5.3 PRODUCT PORTFOLIO 133
    • 13.5.4 RECENT DEVELOPMENTS 133
  • 13.6 ANUNCIA INC 134
    • 13.6.1 COMPANY SNAPSHOT 134
    • 13.6.2 PRODUCT PORTFOLIO 134
    • 13.6.3 RECENT DEVELOPMENT 134
  • 13.7 CHRISTOPH MIETHKE GMBH & CO. KG 135
    • 13.7.1 COMPANY SNAPSHOT 135
    • 13.7.2 PRODUCT PORTFOLIO 135
    • 13.7.3 RECENT DEVELOPMENT 136
  • 13.8 DESU MEDICAL 137
    • 13.8.1 COMPANY SNAPSHOT 137
    • 13.8.2 PRODUCT PORTFOLIO 137
    • 13.8.3 RECENT DEVELOPMENT 137
  • 13.9 G.SURGIWEAR LTD 138
    • 13.9.1 COMPANY SNAPSHOT 138
    • 13.9.2 PRODUCT PORTFOLIO 138
    • 13.9.3 RECENT DEVELOPMENT 138

  • 13.10 HPBIO 139
    • 13.10.1 COMPANY SNAPSHOT 139
    • 13.10.2 PRODUCT PORTFOLIO 139
    • 13.10.3 RECENT DEVELOPMENT 139
  • 13.11 KANEKA MEDIX CORP 140
    • 13.11.1 COMPANY SNAPSHOT 140
    • 13.11.2 REVENUE ANALYSIS 140
    • 13.11.3 PRODUCT PORTFOLIO 142
    • 13.11.4 RECENT DEVELOPMENTS 142
  • 13.12 KARL STORZ SE & CO. KG 143
    • 13.12.1 COMPANY SNAPSHOT 143
    • 13.12.2 PRODUCT PORTFOLIO 143
    • 13.12.3 RECENT DEVELOPMENT 143
  • 13.13 MOLLER MEDICAL GMBH 144
    • 13.13.1 COMPANY SNAPSHOT 144
    • 13.13.2 PRODUCT PORTFOLIO 144
    • 13.13.3 RECENT DEVELOPMENT 144
  • 13.14 NATUS MEDICAL INCORPORATED 145
    • 13.14.1 COMPANY SNAPSHOT 145
    • 13.14.2 PRODUCT PORTFOLIO 145
    • 13.14.3 RECENT DEVELOPMENTS 146
  • 13.15 SOPHYSA 147
    • 13.15.1 COMPANY SNAPSHOT 147
    • 13.15.2 PRODUCT PORTFOLIO 147
    • 13.15.3 RECENT DEVELOPMENTS 148

14 QUESTIONNAIRE 149

15 RELATED REPORTS 152

LIST OF TABLES

  • TABLE 1 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 49
  • TABLE 2 MIDDLE EAST AND AFRICA CONGENITAL HYDROCEPHALUS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 50
  • TABLE 3 MIDDLE EAST AND AFRICA ACQUIRED HYDROCEPHALUS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 50
  • TABLE 4 MIDDLE EAST AND AFRICA NORMAL-PRESSURE HYDROCEPHALUS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 51
  • TABLE 5 MIDDLE EAST AND AFRICA EX-VACUO HYDROCEPHALUS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 51
  • TABLE 6 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 55
  • TABLE 7 MIDDLE EAST AND AFRICA DIAGNOSTIC IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD MILLION) 56
  • TABLE 8 MIDDLE EAST AND AFRICA DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 56
  • TABLE 9 MIDDLE EAST AND AFRICA TREATMENT IN HYDROCEPHALUS MARKET, BY REGION, 2019-2028 (USD MILLION) 57
  • TABLE 10 MIDDLE EAST AND AFRICA TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 57
  • TABLE 11 MIDDLE EAST AND AFRICA SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 58
  • TABLE 12 MIDDLE EAST AND AFRICA HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 58
  • TABLE 13 MIDDLE EAST AND AFRICA SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 59
  • TABLE 14 MIDDLE EAST AND AFRICA TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 60
  • TABLE 15 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 64
  • TABLE 16 MIDDLE EAST AND AFRICA HOSPITALS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 65
  • TABLE 17 MIDDLE EAST AND AFRICA CLINICS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 65
  • TABLE 18 MIDDLE EAST AND AFRICA DIAGNOSTIC CENTERS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 66
  • TABLE 19 MIDDLE EAST AND AFRICA ACADEMIC INSTITUTIONS AND RESEARCH ORGANIZATIONS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 66
  • TABLE 20 MIDDLE EAST AND AFRICA SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 67
  • TABLE 21 MIDDLE EAST AND AFRICA TREATMENT IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 67
  • TABLE 22 ASIA-PACIFIC HYDROCEPHALUS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND) 71
  • TABLE 23 ASIA-PACIFIC HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 71
  • TABLE 24 ASIA-PACIFIC HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 72
  • TABLE 25 ASIA-PACIFIC DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 72
  • TABLE 26 ASIA-PACIFIC TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 72
  • TABLE 27 ASIA-PACIFIC HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 73
  • TABLE 28 ASIA-PACIFIC HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 73
  • TABLE 29 ASIA-PACIFIC SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 73
  • TABLE 30 ASIA-PACIFIC TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 74
  • TABLE 31 ASIA-PACIFIC HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 74
  • TABLE 32 ASIA-PACIFIC SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 74
  • TABLE 33 ASIA-PACIFIC TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 75
  • TABLE 34 JAPAN HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 76
  • TABLE 35 JAPAN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 76
  • TABLE 36 JAPAN DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 76
  • TABLE 37 JAPAN TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 77
  • TABLE 38 JAPAN HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 77
  • TABLE 39 JAPAN HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 77
  • TABLE 40 JAPAN SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 78
  • TABLE 41 JAPAN TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 78
  • TABLE 42 JAPAN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 78
  • TABLE 43 JAPAN SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 79
  • TABLE 44 JAPAN TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 79
  • TABLE 45 CHINA HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 80
  • TABLE 46 CHINA HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 80
  • TABLE 47 CHINA DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 80
  • TABLE 48 CHINA TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 81
  • TABLE 49 CHINA HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 81
  • TABLE 50 CHINA HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 81
  • TABLE 51 CHINA SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 82
  • TABLE 52 CHINA TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 82
  • TABLE 53 CHINA HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 82
  • TABLE 54 CHINA SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 83
  • TABLE 55 CHINA TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 83
  • TABLE 56 SOUTH KOREA HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 84
  • TABLE 57 SOUTH KOREA HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 84
  • TABLE 58 SOUTH KOREA DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 84
  • TABLE 59 SOUTH KOREA TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 85
  • TABLE 60 SOUTH KOREA HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 85
  • TABLE 61 SOUTH KOREA HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 85
  • TABLE 62 SOUTH KOREA SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 86
  • TABLE 63 SOUTH KOREA TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 86
  • TABLE 64 SOUTH KOREA HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 86
  • TABLE 65 SOUTH KOREA SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 87
  • TABLE 66 SOUTH KOREA TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 87
  • TABLE 67 INDIA HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 88
  • TABLE 68 INDIA HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 88
  • TABLE 69 INDIA DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 88
  • TABLE 70 INDIA TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 89
  • TABLE 71 INDIA HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 89
  • TABLE 72 INDIA HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 89
  • TABLE 73 INDIA SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 90
  • TABLE 74 INDIA TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 90
  • TABLE 75 INDIA HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 90
  • TABLE 76 INDIA SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 91
  • TABLE 77 INDIA TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 91
  • TABLE 78 AUSTRALIA HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 92
  • TABLE 79 AUSTRALIA HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 92
  • TABLE 80 AUSTRALIA DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 92
  • TABLE 81 AUSTRALIA TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 93
  • TABLE 82 AUSTRALIA HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 93
  • TABLE 83 AUSTRALIA HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 93
  • TABLE 84 AUSTRALIA SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 94
  • TABLE 85 AUSTRALIA TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 94
  • TABLE 86 AUSTRALIA HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 94
  • TABLE 87 AUSTRALIA SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 95
  • TABLE 88 AUSTRALIA TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 95
  • TABLE 89 SINGAPORE HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 96
  • TABLE 90 SINGAPORE HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 96
  • TABLE 91 SINGAPORE DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 96
  • TABLE 92 SINGAPORE TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 97
  • TABLE 93 SINGAPORE HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 97
  • TABLE 94 SINGAPORE HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 97
  • TABLE 95 SINGAPORE SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 98
  • TABLE 96 SINGAPORE TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 98
  • TABLE 97 SINGAPORE HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 98
  • TABLE 98 SINGAPORE SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 99
  • TABLE 99 SINGAPORE TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 99
  • TABLE 100 THAILAND HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 100
  • TABLE 101 THAILAND HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 100
  • TABLE 102 THAILAND DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 100
  • TABLE 103 THAILAND TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 101
  • TABLE 104 THAILAND HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 101
  • TABLE 105 THAILAND HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 101
  • TABLE 106 THAILAND SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 102
  • TABLE 107 THAILAND TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 102
  • TABLE 108 THAILAND HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 102
  • TABLE 109 THAILAND SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 103
  • TABLE 110 THAILAND TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 103
  • TABLE 111 MALAYSIA HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 104
  • TABLE 112 MALAYSIA HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 104
  • TABLE 113 MALAYSIA DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 104
  • TABLE 114 MALAYSIA TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 105
  • TABLE 115 MALAYSIA HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 105
  • TABLE 116 MALAYSIA HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 105
  • TABLE 117 MALAYSIA SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 106
  • TABLE 118 MALAYSIA TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 106
  • TABLE 119 MALAYSIA HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 106
  • TABLE 120 MALAYSIA SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 107
  • TABLE 121 MALAYSIA TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 107
  • TABLE 122 INDONESIA HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 108
  • TABLE 123 INDONESIA HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 108
  • TABLE 124 INDONESIA DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 108
  • TABLE 125 INDONESIA TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 109
  • TABLE 126 INDONESIA HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 109
  • TABLE 127 INDONESIA HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 109
  • TABLE 128 INDONESIA SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 110
  • TABLE 129 INDONESIA TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 110
  • TABLE 130 INDONESIA HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 110
  • TABLE 131 INDONESIA SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 111
  • TABLE 132 INDONESIA TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 111
  • TABLE 133 PHILIPPINES HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 112
  • TABLE 134 PHILIPPINES HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 112
  • TABLE 135 PHILIPPINES DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 112
  • TABLE 136 PHILIPPINES TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 113
  • TABLE 137 PHILIPPINES HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 113
  • TABLE 138 PHILIPPINES HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 113
  • TABLE 139 PHILIPPINES SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 114
  • TABLE 140 PHILIPPINES TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 114
  • TABLE 141 PHILIPPINES HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 114
  • TABLE 142 PHILIPPINES SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 115
  • TABLE 143 PHILIPPINES TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 115
  • TABLE 144 VIETNAM HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 116
  • TABLE 145 VIETNAM HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 116
  • TABLE 146 VIETNAM DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 116
  • TABLE 147 VIETNAM TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 117
  • TABLE 148 VIETNAM HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 117
  • TABLE 149 VIETNAM HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 117
  • TABLE 150 VIETNAM SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 118
  • TABLE 151 VIETNAM TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 118
  • TABLE 152 VIETNAM HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 118
  • TABLE 153 VIETNAM SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 119
  • TABLE 154 VIETNAM TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 119
  • TABLE 155 REST OF ASIA-PACIFIC HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 120

LIST OF FIGURES

  • FIGURE 1 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET: SEGMENTATION 22
  • FIGURE 2 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET: DATA TRIANGULATION 25
  • FIGURE 3 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET: DROC ANALYSIS 26
  • FIGURE 4 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS 27
  • FIGURE 5 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET: COMPANY RESEARCH ANALYSIS 27
  • FIGURE 6 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET: INTERVIEW DEMOGRAPHICS 29
  • FIGURE 7 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET: DBMR MARKET POSITION GRID 30
  • FIGURE 8 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET: VENDOR SHARE ANALYSIS 31
  • FIGURE 9 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET: SEGMENTATION 34
  • FIGURE 10 INCREASING INCIDENCE OF NEUROLOGICAL CONDITIONS IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET IN THE FORECAST PERIOD OF 2024 TO 2031 35
  • FIGURE 11 CONGENITAL HYDROCEPHALUS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET IN 2024 & 2031 35
  • FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET 39
  • FIGURE 13 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET: BY TYPE, 2023 47
  • FIGURE 14 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET: BY TYPE, 2024-2031 (USD THOUSAND) 48
  • FIGURE 15 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET: BY TYPE, CAGR (2024-2031) 48
  • FIGURE 16 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET: BY TYPE, LIFELINE CURVE 49
  • FIGURE 17 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET: BY DIAGNOSTICS & TREATMENT, 2023 53
  • FIGURE 18 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET: BY DIAGNOSTICS & TREATMENT, 2024-2031 (USD THOUSAND) 54
  • FIGURE 19 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET: BY DIAGNOSTICS & TREATMENT, CAGR (2024-2031) 54
  • FIGURE 20 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET: BY DIAGNOSTICS & TREATMENT, LIFELINE CURVE 55
  • FIGURE 21 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET: BY END USERS, 2023 62
  • FIGURE 22 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET: BY END USERS, 2024-2031 (USD THOUSAND) 63
  • FIGURE 23 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET: BY END USERS, CAGR (2024-2031) 63
  • FIGURE 24 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET: BY END USERS, LIFELINE CURVE 64
  • FIGURE 25 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET: SNAPSHOT (2023) 70
  • FIGURE 26 MIDDLE EAST AND AFRICA HYDROCEPHALUS MARKET: COMPANY SHARE 2023 (%) 121
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!